IE
ANVS icon

Israel Englander’s Annovis Bio ANVS Stock Holding History

Israel Englander’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.6K Buy
+23,463
New +$45.6K ﹤0.01% 5632
2022
Q2 		– Sell
-62,676
Closed -$837K – 6932
2022
Q1 		$837K Sell
62,676
-4,468
-7% -$64.6K ﹤0.01% 4702
2021
Q4 		$1.18M Buy
67,144
+1,525
+2% +$39.3K ﹤0.01% 4259
2021
Q3 		$2.08M Buy
65,619
+62,032
+1,729% +$3.57M ﹤0.01% 3855
2021
Q2 		$307K Buy
+3,587
New +$166K ﹤0.01% 5702
2020
Q3 		– Sell
-38,179
Closed -$166K – 4405
2020
Q2 		$166K Buy
+38,179
New +$158K ﹤0.01% 3889

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Israel Englander's ANVS Position: Q2 2026 in Review

Israel Englander opened a new position in Annovis Bio (ANVS) in Q2 2026: 23,463 shares worth $43.6K. The stake represents ﹤0.01% of the portfolio and ranks #5632 among its holdings. This is a return to the name: Israel Englander previously reported a position in ANVS as recently as Q1 2022.

Israel Englander first reported a position in ANVS in Q2 2020 and has held it in 6 quarters since. The position peaked at $2.08M in Q3 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Israel Englander held 23,463 shares of Annovis Bio worth $43.6K as of Q2 2026.
  • Annovis Bio was a new Israel Englander position in Q2 2026.
  • Annovis Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5632 holding.
  • Israel Englander first reported a position in Annovis Bio in Q2 2020 and has held it in 6 quarters since.
  • Israel Englander's Annovis Bio position peaked at $2.08M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.